The protective effect of bergamot oil extract on lecitine-like oxyLDL receptor-1 expression in balloon injury-related neointima formation

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 13, Issue 2, 2008, Pages 120-129

  Mollace, Vincenzo ^a,b,c,d,g   Ragusa, Salvatore ^a   Sacco, Iolanda ^a   Muscoli, Carolina ^a,b,d   Sculco, Francesca ^a   Visalli, Valeria ^a   Palma, Ernesto ^a   Muscoli, Saverio ^f   Mondello, Luigi ^e   Dugo, Paola ^e   Rotiroti, Domenicantonio ^a   Romeo, Francesco ^f  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c Centro di Ricerca Salus   (Italy)

^d Institute Mondino Tor Vergata   (Italy)

^e UNIVERSITY OF MESSINA   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g University of Catanzaro Magna Graecia   (Italy)

Author keywords

Balloon injury; Bergamot extract; Oxidative stress; OxyLDL

Indexed keywords

3 NITROTYROSINE; BERGAMOT OIL; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CAROTID ARTERY INJURY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MECHANISM; HISTOPATHOLOGY; INTIMA; MALE; NONHUMAN; OXIDATIVE STRESS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER;

ANGIOPLASTY, BALLOON; ANIMALS; ANTIOXIDANTS; CAROTID STENOSIS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICALS; GENE EXPRESSION REGULATION; MALE; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; PLANT OILS; RATS; RATS, WISTAR; SCAVENGER RECEPTORS, CLASS E; SUPEROXIDES; TUNICA INTIMA;

EID: 43949087214     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248407313821     Document Type: Article

References (39)

1. Carter AJ, Laird JR, Farb A., et al. Morphologic characteristics of lesion formation and time course of SMC proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol. 1994 ; 24: 1398-405.
2. Indolfi C., Esposito G., Di Lorenzo E., et al. SMC proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation. 1995 ; 92: 1230-1235.
3. Hoffmann R., Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation. 1996 ; 94: 1247-1254.
4. Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute or threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation. 1992 ; 85: 916-927.
5. Indolfi C., Stabile E., Perrino C., Chiariello M. Mechanisms of restenosis after angioplasty and approach to therapy. Int J Mol Med. 1998 ; 2: 143-148.
6. Holmes DR Jr, Vliestra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty: a report from the PTCA registry of the National Heart, Lung and Blood Institute. Am J Cardiol. 1984 ; 53: 77C - 81C.
7. McBride W., Lange RA, Hillis LD Restenosis after successful coronary angioplasty. N Engl J Med. 1988 ; 318: 1734-1737.
8. Leimgruber PP, Roubin GS, Hollman J., et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation. 1986 ; 73: 710-717.
9. Guiteras Val P., Bourassa MG, David PR, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience. Am J Cardiol. 1987 ; 60 (suppl): 50B - 55B.
10. Asahara T., Bauters C., Pastore C., et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995 ; 91: 2793-2801.
11. Harker LA, Slichter SJ, Scott CR, et al. Homocystinemia: vascular injury and arterial thrombosis. N Engl J Med. 1974 ; 291: 537-543.
12. Serrano C., Ramires J., Venturinelli M., et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecules expression: evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol. 1997 ; 29: 1276-1283.
13. Kastrati A., Koch W., Berger PB, et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol. 2000 ; 36: 2168-2173.
14. Danenberg HD, Welt FGP, Walker M. III, et al. Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation. 2002 ; 105: 2917-2922.
15. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999 ; 340: 115-126.
16. Griendling KK, Sorescu D., Lassegue B., Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscl Thromb Vasc Biol. 2000 ; 20: 2175-2183.
17. Brown MR, Miller FJ Jr, Li WG, et al. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular SMCs. Circ Res. 1999 ; 85: 524-533.
18. Nishio E., Watanabe Y. The involvement of reactive oxygen species and arachidonic acid in α1-adrenoceptor-induced SMC proliferation and migration. Br J Pharmacol. 1997 ; 121: 665-670.
19. Cushing SD, Berliner JA, Valente AJ, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and SMCs. Proc Natl Acad Sci USA. 1990 ; 87: 5134-5138.
20. Li D., Mehta JL Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 2000 ; 101: 2889-2895.
21. Sawamura T., Kume N., Aoyama T., et al. An endothelial receptor for oxidized low density lipoprotein. Nature. 1997 ; 386: 73-77.
22. Kume N., Kita T. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis. Trends Cardiovasc Med. 2001 ; 11: 22-25.
23. Mehta JL, Li D. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol. 2002 ; 39: 1429-1435.
24. Nagase M., Ando K., Nagase T., Kaname S., Sawamura T., Fujita T. Redox-sensitive regulation of lox-1 gene expression in vascular endothelium. Biochem Biophys Res Commun. 2001 ; 281: 720-725.
25. Muscoli C., Sacco I., Alecce W., et al. The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: role of lectin-like oxidized low-density lipoprotein receptor-1. J Pharmacol Exp Ther. 2004 ; 311: 44-50.
26. Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr Pharm Des. 2004 ; 10: 3813-3833.
27. Kris-Etherton PM, Hecker KD, Bonanome A., et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med. 2002 ; 113 (suppl) 9B: 71S - 88S.
28. Gattuso G., Barreca D., Caristi C., Gargiulli C., Leuzzi U. Distribution of flavonoids and furocoumarins in juices from cultivars of Citrus Bergamia Risso. J Agric Food Chem. 2007 ; 55 (24). 9921-9927.
29. Dugo P., Mondello L., Dugo L., et al. LC-MS for the identification of oxygen heterocyclic compounds in citrus essential oils. J Pharm Biomed Anal. 2000 ; 24: 147-154.
30. Dugo P., Presti ML, Ohman M., et al. Determination of flavonoids in citrus juices by micro-HPLC-ESI/MS. J Sep Sci. 2005 ; 28: 1149-1156.
31. Corasaniti MT, Maiuolo J., Maida S., et al. Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro. Br J Pharmacol. 2007 ; 151: 518-529.
32. Nagase M., Abe J., Takahashi K., et al. Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. J Biol Chem. 1998 ; 273: 33702-33707.
33. Kume N., Murase T., Moriwaki H., et al. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res. 1998 ; 83: 322-327.
34. Aoyama T., Fujiwara H., Masaki T., Sawamura T. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. J Mol Cell Cardiol. 1999 ; 31: 2101-2114.
35. Kunsch C., Medford RM Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999 ; 85: 753-766.
36. Hinagata J., Kakutani M., Fujii M., et al. Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. Cardiovas Res. 2006 ; 69: 263-271.
37. Li D., Williams V., Chen H., Sawamura T., et al. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol. 2003 ; 41 (6). 1048-1055.
38. Cominacini L., Pasini AF, Garbin U., et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000 ; 275: 12633-12638.
39. Li D., Romeo F., Mehta JL Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation. 2000 ; 102: 1970-1976.